CytoMed Therapeutics Ltd
For the period ended Dec 31, 2023. Filed Apr 22, 2024.
View on SEC.govAbout this filing
The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.
FY2023 · Filed Apr 22, 2024
Contents
CODE OF ETHICS
ITEM 16B. CODE OF ETHICS
Our Code of Business Conduct and Ethics (“Code of Ethics”) applies to all of our employees, including our chairman, chief financial officer and principal accounting officer. Our Code of Ethics will be available on our corporate website https://www.cytomed.sg/ and is filed as an exhibit to this annual report. Information contained on, or that can be accessed through, our website is not a part of, and shall not be incorporated by reference into, this annual report We will disclose on our website any amendment to, or waiver from, a provision of our Code of Ethics that applies to our directors or executive officers to the extent required under the rules of the SEC.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.